We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Thermal and 3D Imaging to Quantify Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01044823
Recruitment Status : Completed
First Posted : January 8, 2010
Last Update Posted : July 31, 2017
Sponsor:
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by (Responsible Party):
University of Pittsburgh

Brief Summary:
One of the biggest challenges in caring for patients with Rheumatoid Arthritis (RA) and Juvenile Rheumatoid Arthritis (JRA) is quantifying the degree of disease activity in any given joint. We have built a prototype device using well-established sensors to rapidly quantify surface swelling and heat in arthritic joints. The goal of our studies is to test the hypothesis that this Imager can improve the clinical assessment of arthritis.

Condition or disease Intervention/treatment
Rheumatoid Arthritis Juvenile Rheumatoid Arthritis Other: 3D and thermal imaging

Study Type : Observational
Actual Enrollment : 157 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Use of Thermal and 3D Imaging to Quantify Arthritis
Study Start Date : January 2010
Primary Completion Date : March 2011
Study Completion Date : January 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Adult RA Other: 3D and thermal imaging
subjects will be imaged before and after receiving DMARD therapy
pediatric JRA Other: 3D and thermal imaging
subjects will be imaged before and after receiving DMARD therapy




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
children with JRA adults with RA
Criteria

Inclusion Criteria:

  • at least 4 years of age

Exclusion Criteria:

  • less than 4 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01044823


Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224
Sponsors and Collaborators
University of Pittsburgh
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT01044823     History of Changes
Other Study ID Numbers: PRO08040135
R21AR056690 ( U.S. NIH Grant/Contract )
First Posted: January 8, 2010    Key Record Dates
Last Update Posted: July 31, 2017
Last Verified: February 2011

Keywords provided by University of Pittsburgh:
RA
JRA

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Arthritis, Juvenile
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases